Previous studies have shown that abnormal expression of NFIX in tumors can activate the potential of oncogenes or tumor suppressor genes [20–22].In this study, we identified the potential role of NFIX in breast cancer, confirmed its function in vitro and in vivo, and established the potential molecular mechanism through which NFIX inhibits the breast cancer cell cycle. This evidence concerns the gene NFIX and breast carcinoma.